4-Isobutoxybenzylamine N-Phenyl Formate
- CAS1817844-09-9
- CatalogueRS-Z401DOC
- FormulaC18H21NO3
- MW299.15
On this page
Product identification
| Product name | 4-Isobutoxybenzylamine N-Phenyl Formate |
|---|---|
| Catalogue No. | RS-Z401DOC |
| CAS No. | 1817844-09-9 |
| Molecular formula | C18H21NO3 |
| Molecular weight | 299.15 |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | General Reference Standards |
| Drug substance | Pimavanserin |
| Also known as | CATO |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-Z401DOC / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Pimavanserin
- General Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-Z401DOC
- Request a quotation for RS-Z401DOC
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Pimavanserin
All 63 further standards are listed here — every link is in the page, not loaded later.
-
Pimavanserin
IN STOCKRS-U041381 -
Pimavanserin Impurity K
CUSTOM SYNTHESISRS-P094012 -
(4-(sec-Butoxy)phenyl)methanamine hydrochloride
IN STOCKRS-Z401IEL -
(E)-N-(4-Fluorobenzyl)-1-(4-fluorophenyl)methanimine
IN STOCKRS-P012113 -
1-BOC-4-(4-FLUORO-BENZYLAMINO)-PIPERIDINE
BACK ORDERRS-U005A2I -
1-Isobutoxy-4-(isocyanatomethyl)benzene
IN STOCKRS-I516199 -
2,6-Difluorobenzylamine
IN STOCKRS-C002138 -
2-[4-(2-Methylpropoxy)phenyl]acetic acid
IN STOCKRS-P011296 -
2-Fluorobenzylamine
IN STOCKRS-C013044 -
3-(4-(tert-butoxy)benzyl)-1-(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)urea
BACK ORDERRS-U083702 -
4-(2-Methylpropoxy)benzenemethanamine acetate
CUSTOM SYNTHESISRS-I015354 -
4-(2-Methylpropoxy)benzonitrile
IN STOCKRS-U010342 -
[2-(2-methylpropoxy)phenyl]methanamine
BACK ORDERRS-U010A7A -
[3-(2-methylpropoxy)phenyl]methanamine
BACK ORDERRS-U053754 -
Methyl 2-(4-Isobutoxyphenyl)acetate
IN STOCKRS-P140214 -
N-Desmethyl Pimavanserin
BACK ORDERRS-Z412M6Y -
Pimavanserin D4
BACK ORDERRS-Z400H5E -
Pimavanserin Impurity reference
BACK ORDERRS-P094023 -
Pimavanserin N-Oxide
BACK ORDERRS-I001058 -
Pimavanserin-d9
BACK ORDERRS-P094026 -
α,α',α''-Nitrilotri-p-cresol
IN STOCKRS-U054383 -
Pimavanserin Impurity 1
CUSTOM SYNTHESISRS-P094022 -
Pimavanserin Impurity 1 (2HCl Salt)
CUSTOM SYNTHESISRS-P094007 -
Pimavanserin Impurity 2
IN STOCKRS-P094006 -
Pimavanserin Impurity 2 Monomer
IN STOCKRS-P094010 -
Pimavanserin Impurity 4
IN STOCKRS-P136001 -
Pimavanserin Impurity 4
IN STOCKRS-Z401IPT -
Pimavanserin Impurity 5
BACK ORDERRS-P094014 -
Pimavanserin Impurity 6
IN STOCKRS-P094001 -
Pimavanserin Impurity 7 (932724-63-5)
IN STOCKRS-P094031 -
Pimavanserin Impurity 8
CUSTOM SYNTHESISRS-P094025 -
Pimavanserin Impurity 19 HCl
BACK ORDERRS-P094003 -
Pimavanserin Impurity 28
IN STOCKRS-P094041 -
Pimavanserin Impurity 29 Monomer
IN STOCKRS-P094019 -
Pimavanserin Impurity 30
CUSTOM SYNTHESISRS-I001AQE -
Pimavanserin Impurity 34
CUSTOM SYNTHESISRS-U211O66 -
Pimavanserin Impurity 35
CUSTOM SYNTHESISRS-I516302 -
Pimavanserin Impurity 37
IN STOCKRS-P094017 -
Pimavanserin Impurity 38
IN STOCKRS-P094005 -
Pimavanserin Impurity 47
CUSTOM SYNTHESISRS-P094028 -
Pimavanserin Impurity 49
IN STOCKRS-P094035 -
Pimavanserin Impurity 53
CUSTOM SYNTHESISRS-P094036 -
Pimavanserin Impurity 63
IN STOCKRS-P094037 -
Pimavanserin Impurity 65
CUSTOM SYNTHESISRS-P094018 -
Pimavanserin Impurity 67
CUSTOM SYNTHESISRS-P094008 -
Pimavanserin Impurity 68
IN STOCKRS-P094009 -
Pimavanserin Impurity 69
IN STOCKRS-P094011 -
Pimavanserin Impurity 70
BACK ORDERRS-P094013 -
Pimavanserin Impurity 71
IN STOCKRS-P094032 -
Pimavanserin Impurity 72
IN STOCKRS-P094033 -
Pimavanserin Impurity 76
IN STOCKRS-P094043 -
Pimavanserin Impurity 90
IN STOCKRS-P094002 -
Pimavanserin Impurity 91
BACK ORDERRS-P094004 -
Pimavanserin Impurity 92
IN STOCKRS-P094015 -
Pimavanserin Impurity 93
IN STOCKRS-P094016 -
Pimavanserin Impurity 95
BACK ORDERRS-P094021 -
Pimavanserin Impurity 96
IN STOCKRS-P094024 -
Pimavanserin Impurity 97
IN STOCKRS-P094027 -
Pimavanserin Impurity 98
IN STOCKRS-P094029 -
Pimavanserin Impurity 99
IN STOCKRS-P094030 -
Pimavanserin Impurity 100
IN STOCKRS-P094034 -
Pimavanserin Impurity 102
IN STOCKRS-P094040 -
Pimavanserin Impurity 103
IN STOCKRS-P094045
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.







![Chemical structure of 2-[4-(2-Methylpropoxy)phenyl]acetic acid](/structures/w4/APXLSLWSMWRTTL-UHFFFAOYSA-N.webp?v=9)




![Chemical structure of [2-(2-methylpropoxy)phenyl]methanamine](/structures/w4/KJYRIJFDSZQEHR-UHFFFAOYSA-N.webp?v=9)
![Chemical structure of [3-(2-methylpropoxy)phenyl]methanamine](/structures/w4/DLOAJJCCFGJMBQ-UHFFFAOYSA-N.webp?v=9)














































